Revance is advancing treatment options for movement disorders with DAXXIFY® (daxibotulinumtoxinA-lanm) for injection, the first and only botulinum toxin made with a custom-engineered peptide. This differentiated formulation is designed to provide consistent clinical outcomes with an excellent safety profile, addressing a critical unmet need in cervical dystonia.